A Canadian company says it has a vaccine for the coronavirus.
Medicago, a biopharmaceutical company headquarter in Quebec City that uses plant-based technology to produce vaccines, said it has produced a Virus-Like Particle of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene.
"Production of the VLP is the first step in developing a vaccine for COVID-19, which will now undergo preclinical testing for safety and efficacy," the company said in a press release. "Once this is completed, Medicago expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020."
Medicago CEO Bruce Clark said his company could produce as many as 10 million doses a month. The vaccine, he said, could become available in November if regulatory hurdles can be cleared.
"There are a couple of others who are claiming that they have — well, we will call them vaccine[s]" for COVID-19, he told Defense One. "But they're different technologies. Some are RNA- or DNA-based vaccines that have not yet been proven in any indication yet, let alone this one. Hopefully, they'll be successful."
Solange Reyner ✉
Solange Reyner is a writer and editor for Newsmax. She has more than 15 years in the journalism industry reporting and covering news, sports and politics.
© 2025 Newsmax. All rights reserved.